Skip to search boxSkip to navigationSkip to main content

The neural progenitor-restricted isoform of the MARK4 gene in 19q13.2 is upregulated in human gliomas and overexpressed in a subset of glioblastoma cell lines

  • Alessandro Beghini(corresponding author)
    ,
  • Ivana Magnani
    ,
  • Gaia Roversi
    ,
  • Tiziana Piepoli
    ,
  • Simona Di Terlizzi
    ,
  • Ramona F. Moroni
*Corresponding author for this work
  • University of Milan
    ,
  • IRCCS Fondazione Istituto Neurologico Carlo Besta - Milano
    ,
  • Roswell Park Cancer Institute
Scholary Output:
Contribution to journal
Article
Peer-review

Open access

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

Alterations of 19q13 are frequently observed in glial neoplasms, suggesting that this region harbors at least one gene involved in gliomagenesis. Following our previous studies on structural 19q chromosome rearrangements in gliomas, we have undertaken a detailed FISH analysis of the breakpoints and identified a 19q13.2 intrachromosoreal amplification of the MAP/microtubule affinity-regulating kinase 4 (MARK4) gene in three primary glioblastoma cell lines. Recent data suggest that this gene is involved in the Wnt-signaling pathway. We observed that the expression of the alternatively spliced MARK4L isoform is upregulated in both fresh and cultured gliomas and overexpressed in all of the above three glioblastoma cell lines. Interestingly, we also found that MARK4L expression is restricted to undifferentiated neural progenitor cells or proliferating glial precursor cells, whereas its expression is downregulated during glial differentiation. Perturbation of expression using antisense oligonucleotides against MARK4 in glioblastoma cell lines, consistently induced a decreased proliferation of tumor cells. Taken together, these data show that MARK4, which is normally expressed in neural progenitors, is reexpressed in gliomas and may become a key target of intrachromosomal amplification upon 19q rearrangements.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 2581-2591 (11 pages)

Journal (Volume, Issue Number)

Oncogene (Volume 22, Issue 17)

Publication milestones

  • Published - 05/01/2003

Publication status

Published - 05/01/2003

ISSN

0950-9232

Publication IDs

  • Scopus: 0038530985
  • PubMed: 12735302

Publication metrics

Metrics

Scopus
citations
SciVal
citations
54
Fractional count
1
Fractional count
0.09
Fractional count
10
Fractional count
0.91
Fractional count
1
Fractional count
1
SciVal
FWCI
0.81
SciVal
Author count
11
SciVal
Paper percentile
87

PlumX, opens in new tab

Mentions
1
Captures
25
Citation count
74

Funding Details

We thank Lawrence Livermore National Laboratory for providing cosmids LLNL-R32611, LLNL-F18718, LLNL-R31237, LLNL-R33632, LLNL-F19186, LLNL-F15123, LLNL-F10080, LLNL-F13544, LLNL-F20720 and LLNL-R32889. This research was supported by AIRC (Associazione Italiana Ricerca sul Cancro) 2001 (LL and GF) and in part from Grant CA76457 from the National Institutes of Health (JKC)
FundersFunding number
JKC
-
NIH
-
NCI
R01CA076457
AIRC
-